Medifast Inc (MED)
12.51 x 1 13.66 x 1
Post-market by (Cboe BZX)
13.19 +0.13 (+1.00%) 04/04/25 [NYSE]
12.51 x 1 13.66 x 1
Post-market 13.19 unch (unch) 16:02 ET
for Fri, Apr 4th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | 2,091 | 99,415 | 143,568 | 164,031 | 102,859 |
Depreciation Amortization | 11,908 | 12,938 | 10,994 | 6,901 | 4,636 |
Income taxes - deferred | -7,403 | 1,211 | -924 | -3,715 | 601 |
Other Working Capital | -9,745 | 20,276 | 21,651 | -87,646 | 26,903 |
Other Operating Activity | 27,625 | 13,817 | 19,281 | 14,974 | 10,197 |
Operating Cash Flow | $24,476 | $147,657 | $194,570 | $94,545 | $145,196 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -19,066 | -54,564 | 5,267 | 5,145 | 4,605 |
PPE Investments | -7,454 | -6,483 | -16,681 | -34,209 | -5,887 |
Investing Cash Flow | $-26,520 | $-61,047 | $-11,414 | $-29,064 | $-1,282 |
Cash Flows From Financing Activities | |||||
Common Stock Issued | 36 | 188 | N/A | 811 | 1,597 |
Common Stock Repurchased | -836 | -6,960 | -127,961 | -62,088 | -5,551 |
Dividend Paid | -715 | -73,017 | -71,620 | -63,856 | -53,190 |
Financing Cash Flow | $-1,515 | $-79,789 | $-199,581 | $-125,133 | $-57,144 |
Exchange Rate Effect | 47 | -72 | -67 | 112 | -21 |
Beginning Cash Position | 94,440 | 87,691 | 104,183 | 163,723 | 76,974 |
End Cash Position | 90,928 | 94,440 | 87,691 | 104,183 | 163,723 |
Net Cash Flow | $-3,512 | $6,749 | $-16,492 | $-59,540 | $86,749 |
Free Cash Flow | |||||
Operating Cash Flow | 24,476 | 147,657 | 194,570 | 94,545 | 145,196 |
Capital Expenditure | -7,454 | -6,483 | -16,681 | -34,209 | -5,887 |
Free Cash Flow | 17,022 | 141,174 | 177,889 | 60,336 | 139,309 |